According to a recent LinkedIn post from Glooko, the company is drawing attention to its electronic health record integrations for outpatient diabetes care. The post points to an on-demand webinar featuring clinicians from Rady Children’s Hospital-San Diego and Michigan Medicine, who discuss how integrating diabetes data into the EHR may improve efficiency and care coordination.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post highlights Glooko’s focus on embedding diabetes data directly into clinical workflows rather than operating as a standalone tool. For investors, this emphasis on EHR integration suggests a strategy aimed at deeper adoption within health systems, potentially supporting recurring enterprise revenue and strengthening switching costs for providers.
By showcasing real-world use at prominent U.S. institutions, the content appears designed to build validation and credibility in the hospital and health-system segment. If such integrations scale across more systems, Glooko could improve its competitive position in digital diabetes management, positioning the platform as infrastructure-like rather than optional software.
The educational framing via webinar also indicates a demand-generation approach that targets clinical decision-makers rather than consumers. This could translate into longer sales cycles but larger contract values, which may be relevant for investors assessing the company’s growth trajectory and the defensibility of its health-system relationships.